Some of the stories that caught my attention:

• New recommendations have been published by ASCO on the use of biomarkers to guide in the treatment for metastatic breast cancer.
• Researchers at Cedars-Sinai have discovered a genetic biomarker responsible for the progression of many breast and prostate cancers. The findings could help to contribute to better identify patients who respond to certain types of chemotherapy drugs. Read more about the findings in the journal Scientific Reports.
• Scientists at MD Anderson have found a link between a protein called CSN6 and patients with colorectal cancer. The results of the study have been published in the journal Cancer Cell.
• According to a recent study published in the Journal of Investigative Dermatology, soldiers returning home from Iraq and Afghanistan have an increased risk of developing skin cancer.
• The Obama administration announced that Medicare will start paying for the cancer drug Blincyto produced by Amgen Inc. It is currently used to treat a rare form of acute lymphoblastic leukemia.

Some of the stories that caught my attention:

• An upcoming paper in the August issue of the Mayo Clinic Proceedings sheds light on the high price of cancer drugs and the implications for patients and the health care system. The report also provides recommendations on potential ways to reduce the financial strain.
• The Harper government in Canada announced funding for a new breast imaging tool that may help reduce additional follow-up surgeries for breast cancer patients. Perimeter Medical Imaging Inc, a medical device company based in Toronto, will develop and test the new tool.
• Researchers at the Roswell Park Cancer Institute have identified that age and fear of cancer diagnosis are among the reasons why there are high rates of Latina women that do not continue participation following breast and cervical cancer education programs. The research was published in the Journal of Health Communication.